TrialHeadache2019

Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials.

Virginia L Stauffer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.